Chemoinformaics analysis of 6-HYDROXYCARVOTANACETONE
| Molecular Weight | 168.236 | nRot | 1 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 8 |
| Exact Molecular Weight | 168.115 | nRing | 1 |
| Solubility: LogS | -2.867 | nHRing | 0 |
| Solubility: LogP | 2.222 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 28.9727 |
| nHD | 1 | BPOL | 16.9193 |
| QED | 0.56 |
| Synth | 3.541 |
| Natural Product Likeliness | 1.305 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.013 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.449 |
| MDCK | 0.0000315 |
| BBB | 0.688 |
| PPB | 0.914159 |
| VDSS | 0.414 |
| FU | 0.0595009 |
| CYP1A2-inh | 0.336 |
| CYP1A2-sub | 0.676 |
| CYP2c19-inh | 0.116 |
| CYP2c19-sub | 0.877 |
| CYP2c9-inh | 0.114 |
| CYP2c9-sub | 0.261 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.499 |
| CYP3a4-inh | 0.056 |
| CYP3a4-sub | 0.49 |
| CL | 7.522 |
| T12 | 0.401 |
| hERG | 0.011 |
| Ames | 0.287 |
| ROA | 0.268 |
| SkinSen | 0.174 |
| Carcinogencity | 0.321 |
| EI | 0.885 |
| Respiratory | 0.644 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.944014 |